Bioactive Lipid Mediators in Cardiopulmonary Pharmacology

Author:   Darryl C Zeldin (National Institutes of Health/National Institute of Environmental Health Services, NC, USA) ,  John Seubert (University of Alberta Faculty of Medicine and Dentistry, Edmonton, Canada)
Publisher:   Elsevier Science & Technology
ISBN:  

9780323950572


Pages:   462
Publication Date:   25 May 2023
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $457.99 Quantity:  
Add to Cart

Share |

Bioactive Lipid Mediators in Cardiopulmonary Pharmacology


Add your own review!

Overview

Full Product Details

Author:   Darryl C Zeldin (National Institutes of Health/National Institute of Environmental Health Services, NC, USA) ,  John Seubert (University of Alberta Faculty of Medicine and Dentistry, Edmonton, Canada)
Publisher:   Elsevier Science & Technology
Imprint:   Academic Press Inc
Weight:   0.870kg
ISBN:  

9780323950572


ISBN 10:   0323950574
Pages:   462
Publication Date:   25 May 2023
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Preface Darryl C. Zeldin and John Seubert 1. Bioactive lipids in hypertension John D. Imig 2. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response Mohammed A. Nayeem, Werner J. Geldenhuys and Ahmad Hanif 3. Cyclooxygenases, eicosanoids and platelets Annalisa Bruno, Stefania Tacconelli, Annalisa Contursi, Patrizia Ballerini and Paola Patrignani 4. The roles of eicosanoids in myocardial diseases Zuowen He and Dao Wen Wang 5. Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ?-3 and ?-6 PUFAs Christi Cho, Theresa Aliwarga, Alexandra M. Wiley and Rheem A. Totah 6. 20-Hydroxyeicosatetraenoic acid (20-HETE): Bioactions, receptors, vascular function, cardiometabolic disease and beyond Jonathan V. Pascale, Alexandra Wolf, Yonaton Kadish, Danielle Diegisser, Melissa-Maria Kulaprathazhe, Danait Yemane, Samir Ali, Namhee Kim, David E. Baruch, Muhamad Afiq Faisal Bin Yahaya, Ercument Dirice, Adeniyi M. Adebesin, John R. Falck, Michal L. Schwartzman and Victor Garcia 7. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease Matthew Spite and Gabrielle Fredman 8. Cytochrome P450-derived eicosanoids in brain: From basic discovery to clinical translation Catherine M. Davis, Aseel H. Ibrahim and Nabil J. Alkayed 9. Lipid mediators generated by the cytochrome P450: Epoxide hydrolase pathway Timo Frömel, Jiong Hu and Ingrid Fleming 10. Role of omega-3 and omega-6 endocannabinoids in cardiopulmonary pharmacology Tiffany Y.-C. Tang, Justin S. Kim and Aditi Das 11. Oxylipins in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) Kimberley Cousins, Chien-Chang Chen, Esha Sehanobish and Elina Jerschow

Reviews

Author Information

Dr. Darryl Zeldin is a Senior Investigator and the Scientific Director at the National Institute of Environmental Health Sciences, National Institutes of Health (NIH/NIEHS). He obtained his MD degree from Indiana University School of Medicine, completed his Internship/Residency in Internal Medicine at Duke University Medical Center and his Pulmonary/Critical Care Fellowship at Vanderbilt University Medical Center. His research program focuses on understanding the role of eicosanoids in regulating pulmonary and cardiovascular function. He is a Fellow in the American College of Chest Physicians, a Fellow in the American Heart Association and is an elected member of the American Society for Clinical Investigation and American Association of Physicians. He has co-authored over 380 primary peer-reviewed articles and his work has been cited over 33,000 times. He has mentored over 85 post-baccalaureate fellows, graduate students, medical students, postdoctoral research fellows and clinical research fellows. As the NIEHS Scientific Director, he is responsible for one of the largest intramural research programs at the NIH with over 600 scientists in 11 Departments and 17 Core Facilities. Dr. John M. Seubert is a Professor in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta. He obtained his MSc in Biological Sciences (Simon Fraser University), PhD in Pharmacology and Toxicology (University of Western Ontario) and a Postdoctoral Fellowship in Cardiovascular Pharmacology at the National Institute of Environmental Health Sciences, National Institutes of Health (NIH/NIEHS). His research program focuses on the biological role essential fatty acids have in cardiac homeostasis and pathology. A central theme involves understanding the role the cytochrome P450 system has within the cell to assist in the development novel drug targets and strategies to limit injury. He is an adjunct professor in the Department of Pharmacology, Faculty of Medicine and Dentistry at the University of Alberta. He has co-authored over 78 primary peer-reviewed articles. He has mentored over 90 undergraduate students, pharmacy students, graduate students, postdoctoral research fellows and research fellows. His research has been funded by the Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List